JP2021530562A5 - - Google Patents
Info
- Publication number
- JP2021530562A5 JP2021530562A5 JP2021522113A JP2021522113A JP2021530562A5 JP 2021530562 A5 JP2021530562 A5 JP 2021530562A5 JP 2021522113 A JP2021522113 A JP 2021522113A JP 2021522113 A JP2021522113 A JP 2021522113A JP 2021530562 A5 JP2021530562 A5 JP 2021530562A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide
- ala
- trp
- tyr
- Prior art date
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862694162P | 2018-07-05 | 2018-07-05 | |
| US62/694,162 | 2018-07-05 | ||
| US16/502,215 US10905738B2 (en) | 2018-07-05 | 2019-07-03 | Synthetic peptides, prodrugs, pharmaceutical compositions and uses |
| US16/502,215 | 2019-07-03 | ||
| PCT/BR2019/050249 WO2020006617A1 (en) | 2018-07-05 | 2019-07-04 | Synthetic peptides, prodrugs, pharmaceutical compositions and uses |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021530562A JP2021530562A (ja) | 2021-11-11 |
| JP2021530562A5 true JP2021530562A5 (https=) | 2022-06-24 |
| JPWO2020006617A5 JPWO2020006617A5 (https=) | 2022-06-24 |
| JP7317956B2 JP7317956B2 (ja) | 2023-07-31 |
Family
ID=69059636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021522113A Active JP7317956B2 (ja) | 2018-07-05 | 2019-07-04 | 合成ペプチド、プロドラッグ、医薬組成物および使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10905738B2 (https=) |
| EP (1) | EP3818070B1 (https=) |
| JP (1) | JP7317956B2 (https=) |
| KR (1) | KR20210029161A (https=) |
| CN (1) | CN112654634B (https=) |
| BR (1) | BR112021000105A2 (https=) |
| CA (1) | CA3104183A1 (https=) |
| WO (1) | WO2020006617A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026507422A (ja) * | 2023-02-17 | 2026-03-04 | バイオゼウス バイオファーマシューティカル エス.エー. | 性機能障害の治療のための局所用ペプチド製剤 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| AT387234B (de) | 1987-03-05 | 1988-12-27 | Vogelbusch Gmbh | Vorrichtung zur zuechtung von dauerformen insbesondere filamentoeser mikroorganismen |
| US5470949A (en) | 1992-12-15 | 1995-11-28 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Method for making amino acid glycosides and glycopeptides |
| IL128332A0 (en) | 1996-08-30 | 2000-01-31 | Novo Nordisk As | GLP-1 derivatives |
| AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| US20030082671A1 (en) | 2001-07-24 | 2003-05-01 | Thomas Hoeg-Jensen | Method for making acylated polypeptides |
| US7585523B2 (en) | 2002-08-27 | 2009-09-08 | Targeted Medical Pharma | Composition and method to augment and sustain neurotransmitter production |
| CA2560956A1 (en) | 2004-03-29 | 2005-10-20 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Amphipathic glycopeptides |
| CN101563102B (zh) | 2006-09-22 | 2014-12-17 | 德克萨斯系统大学董事会 | 治疗内皮功能障碍的方法 |
| KR20090115852A (ko) | 2007-01-19 | 2009-11-09 | 카이 파마슈티컬즈 | 안정성 및 전달 효율을 증가시키기 위한 펩타이드 조성물의 변형 |
| BRPI0800596A2 (pt) | 2008-01-31 | 2009-09-22 | Univ Minas Gerais | método para a potencialização da função erétil através do uso das composições farmacêuticas de toxina tx2-6 da aranha phoneutria nigriventer |
| CN101585872A (zh) | 2008-05-23 | 2009-11-25 | 成都蓉药集团四川长威制药有限公司 | 重组蛛毒蛋白、其制备方法和表达载体以及用于治疗ed的药物 |
| KR20130139254A (ko) | 2010-11-09 | 2013-12-20 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 피부 침투 및 세포 진입(space) 펩타이드 및 그의 사용방법 |
| PT2899198T (pt) * | 2012-08-20 | 2018-06-29 | Univ Federal De Minas Gerais Ufmg | Péptido sintético pntx(19), composições farmacêuticas e utilização |
| UY35144A (es) | 2012-11-20 | 2014-06-30 | Novartis Ag | Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca |
| WO2015162195A1 (en) | 2014-04-23 | 2015-10-29 | Novo Nordisk A/S | Fatty acid acylated amino acids for oral peptide delivery |
| WO2017068388A2 (pt) | 2015-09-18 | 2017-04-27 | Universidade Federal De Minas Gerais - Ufmg | Uso do peptideo sintetico pntx-19 para tratamento de dor |
| KR101613302B1 (ko) | 2015-12-30 | 2016-04-18 | (주)넥스젠바이오텍 | Sv82 폴리펩타이드 및 이를 유효성분으로 함유하는 피부 주름 개선 및 탄력 유지용 화장료 조성물 |
| KR101636851B1 (ko) | 2016-06-03 | 2016-07-06 | (주)넥스젠바이오텍 | 피부 세포 증식 효과가 증가한 열 안정성 인간 상피세포성장인자-거미독 융합단백질 및 이를 유효성분으로 함유하는 피부 주름 개선 및 탄력 유지용 화장료 조성물 |
-
2019
- 2019-07-03 US US16/502,215 patent/US10905738B2/en active Active
- 2019-07-04 BR BR112021000105-0A patent/BR112021000105A2/pt unknown
- 2019-07-04 CN CN201980057994.1A patent/CN112654634B/zh active Active
- 2019-07-04 KR KR1020207037684A patent/KR20210029161A/ko active Pending
- 2019-07-04 EP EP19830422.2A patent/EP3818070B1/en active Active
- 2019-07-04 CA CA3104183A patent/CA3104183A1/en active Pending
- 2019-07-04 WO PCT/BR2019/050249 patent/WO2020006617A1/en not_active Ceased
- 2019-07-04 JP JP2021522113A patent/JP7317956B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0651765B1 (en) | Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis | |
| CN102596217B (zh) | 经修饰的血管活性肠肽 | |
| TWI388333B (zh) | 具有改良性質之重組表面張力素 | |
| CN100354306C (zh) | Glp-1衍生物及其经粘膜吸收的制剂 | |
| KR20070050454A (ko) | 섬유아세포 성장 인자 21의 뮤테인 | |
| CN115768460A (zh) | 长效glp-1/gip双重激动剂 | |
| WO2008056726A1 (en) | Glp-1 derivative and use thereof | |
| JPH06228199A (ja) | 血液脳関門通過可能なペプチド結合体 | |
| CN112334477A (zh) | 具有增加的溶解度和改善的药代动力学特性的坎普他汀类似物 | |
| JP2026041880A (ja) | 細胞透過性ペプチド変異体およびその用途 | |
| EP2185588B1 (en) | Synthetic pulmonary surfactant peptides | |
| JP2005053929A (ja) | 肺胞界面活性タンパク質 | |
| JP2021530562A5 (https=) | ||
| JP2021516222A5 (https=) | ||
| JPWO2020006617A5 (https=) | ||
| JPH06220090A (ja) | ポリペプチド | |
| US12606609B2 (en) | Polypeptides having improved properties | |
| WO2026055636A1 (en) | Peptides and compositions for improving glucose levels | |
| JPH11100399A (ja) | 新規ペプチド誘導体およびそれを有効成分とする薬剤 | |
| JP2004315436A (ja) | 慢性肺疾患治療剤 | |
| JPWO2021209607A5 (https=) | ||
| WO2019067887A1 (en) | ENAC INHIBITOR PEPTIDES AND USES THEREOF | |
| HK1144435A (en) | Synthetic pulmonary surfactant peptides | |
| JPH08333276A (ja) | ペプチド及び気管支拡張剤 |